genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
Newron Pharmaceuticals SpA
Industry News
Newron to Buy NeuroNova for €15.4 in Shares for Clinical ALS and Parkinson Disease Drugs
Industry News
Biotie Axes Agreement to Acquire Newron on Latter’s Loss of Partner for Parkinson Disease Drug
News
Merck Serono Hands Parkinson Disease Drug Safinamide Back to Newron
News
Biotie to Buy Newron in €45M Share-Based Deal
News
Newron Pharmaceuticals Nabs Two Candidates from Merck Serono’s Pipeline
Industry News
Newron Raises CHF 7.9M to Help Progress Clinical Trials and Pipeline Development
News
Newron Acquires Hunter-Fleming for $11.6M Upfront
Scroll Up
Scroll Up
